[Retracted] Bevacizumab Combined with Intensity-Modulated Radiation Therapy on Cognitive and Coagulation Function in Postoperative Glioma Patients
Table 3
Comparison of coagulation indexes (‾x ± s).
Time point
Group
TT (s)
PT (s)
APTT (s)
FIB (g/L)
D-d (mg/L)
Before radiotherapy
Control group (n = 77)
17.85 ± 1.34
11.07 ± 1.17
24.52 ± 2.41
2.93 ± 0.31
0.32 ± 0.14
Observation group (n = 79)
17.69 ± 1.43
11.32 ± 1.25
24.02 ± 2.49
3.01 ± 0.37
0.35 ± 0.11
t
0.7207
1.2889
1.2739
1.4619
1.4903
P
0.4722
0.1994
0.2046
0.1458
0.1382
3 months after radiotherapy
Control group (n = 77)
17.63 ± 1.56
10.18 ± 1.21
23.37 ± 2.51
3.41 ± 0.27
0.50 ± 0.13
Observation group (n = 79)
17.52 ± 1.50
9.98 ± 1.04
21.05 ± 2.04
3.69 ± 0.35
0.59 ± 0.18
t
0.4489
1.9842
6.3427
5.5846
3.5723
P
0.6541
0.0490
<0.0001
<0.0001
0.0005
Notes: TT: thrombin time; PT: prothrombin time; APTT: activated partial thromboplastin time; FIB: fibrinogen; D-D : D-Dimer; P < 0.0500, compared to the same group before radiotherapy using paired t-test and independent sample T test between groups. The bolded part represents statistical significance, p < 0.05.
